Panodil oral suspension

Panodil is a well-known brand of paracetamol-based medication, specifically an oral suspension for children as shown in the image. The brand is originally a Nordic variant of the global Panadol brand, which was founded by Sterling Drug in the United States.

Starting from 2022, the consumer healthcare division of GlaxoSmithKline (GSK) was spun off into an independent company called Haleon. Haleon now holds the ultimate ownership of the Panodil brand worldwide. While Haleon is headquartered in the United Kingdom, production for the European market occurs across multiple manufacturing sites globally, including facilities in France and the UK, to ensure widespread distribution.